Gender-related immune-inflammatory factors, age-related diseases, and longevity.

This review discusses the role of estrogens as pro- or antiinflammatory players in immune-inflammatory responses. In particular, their role in Alzheimer's disease (AD), an example of immune-inflammatory disease, is discussed briefly. AD is a progressive neurodegenerative disease, which in Western societies accounts for the majority of cases of clinical senile dementia. However, sexual dimorphism of diseases may also depend on factors independent of sex hormones (i.e., a gender effect), as demonstrated by our data on differential longevity in females and males. In fact, differences in mortality between men and women are not only a question of sex that refers to biological differences, but rather a question of "socially constructed sex," a question of gender (i.e., the characteristics that a society or culture delineates as masculine or feminine). In gender medicine, we conclude that it is important to consider the role played both by hormones, customs, and educational levels regarding the different propensity of males and females to fall ill. So, in programming antiaging strategies, we have also to take these aspects into account.

[1]  Aubrey D N J de Grey Consolidating the mission to defeat aging: a big step forward. , 2008, Rejuvenation research.

[2]  J. Nilsen Estradiol and neurodegenerative oxidative stress , 2008, Frontiers in Neuroendocrinology.

[3]  C. Caruso,et al.  A scientific approach to anti-ageing therapies: state of the art. , 2008, Current pharmaceutical design.

[4]  S. Davidge,et al.  Estrogen is a modulator of vascular inflammation , 2008, IUBMB life.

[5]  Domenico Lio,et al.  Inflammation, genes and zinc in Alzheimer's disease , 2008, Brain Research Reviews.

[6]  I. Chaudry,et al.  Estrogen: A Novel Therapeutic Adjunct for the Treatment of Trauma-Hemorrhage—Induced Immunological Alterations , 2008, Molecular medicine.

[7]  K. Ritchie,et al.  Hormonal treatment, mild cognitive impairment and Alzheimer's disease , 2008, International Psychogeriatrics.

[8]  D. Mari,et al.  Human longevity within an evolutionary perspective: The peculiar paradigm of a post-reproductive genetics , 2008, Experimental Gerontology.

[9]  C. Franceschi,et al.  The extreme longevity: The state of the art in Italy , 2008, Experimental Gerontology.

[10]  C. Caruso,et al.  Alzheimer's disease and genetics of inflammation: a pharmacogenomic vision. , 2007, Pharmacogenomics.

[11]  C. Franceschi,et al.  Pathophysiology of ageing, longevity and age related diseases , 2007, Immunity & Ageing.

[12]  R. May Gender, immunity and the regulation of longevity. , 2007, BioEssays : news and reviews in molecular, cellular and developmental biology.

[13]  R. Straub,et al.  The complex role of estrogens in inflammation. , 2007, Endocrine reviews.

[14]  B. Nilsson Modulation of the inflammatory response by estrogens with focus on the endothelium and its interactions with leukocytes , 2007, Inflammation Research.

[15]  J. Rigby,et al.  Mortality in relation to sex in the affluent world , 2007, Journal of Epidemiology and Community Health.

[16]  C. Franceschi,et al.  Immunogenetics, Gender, and Longevity , 2006, Annals of the New York Academy of Sciences.

[17]  F. Licastro,et al.  Age‐Related Inflammatory Diseases , 2006 .

[18]  I. Chaudry,et al.  Gender and sex hormones influence the response to trauma and sepsis: potential therapeutic approaches. , 2006, Clinics.

[19]  A. Członkowska,et al.  Gender differences in neurological disease , 2006, Endocrine.

[20]  V. W. Henderson,et al.  Estrogen-containing hormone therapy and Alzheimer’s disease risk: Understanding discrepant inferences from observational and experimental research , 2006, Neuroscience.

[21]  J. Sastre,et al.  Why females live longer than males: control of longevity by sex hormones. , 2005, Science of aging knowledge environment : SAGE KE.

[22]  S. Shumaker,et al.  Conjugated equine estrogens and incidence of probable dementia and mild cognitive impairment in postmenopausal women: Women's Health Initiative Memory Study. , 2004, JAMA.

[23]  G. Wooten,et al.  Postmenopausal estrogen use affects risk for Parkinson disease. , 2004, Archives of neurology.

[24]  Robert B Wallace,et al.  Estrogen plus progestin and the incidence of dementia and mild cognitive impairment in postmenopausal women: the Women's Health Initiative Memory Study: a randomized controlled trial. , 2003, JAMA.

[25]  C. Franceschi,et al.  Association between the HFE mutations and longevity: a study in Sardinian population , 2003, Mechanisms of Ageing and Development.

[26]  J. Sastre,et al.  Mitochondria from females exhibit higher antioxidant gene expression and lower oxidative damage than males. , 2003, Free radical biology & medicine.

[27]  E. Hogervorst,et al.  HRT and cognitive decline , 2003 .

[28]  G. Perry,et al.  Amyloid-β, tau alterations and mitochondrial dysfunction in Alzheimer disease: the chickens or the eggs? , 2002, Neurochemistry International.

[29]  J. Vandenbroucke,et al.  Female hormones and thrombosis. , 2002, Arteriosclerosis, thrombosis, and vascular biology.

[30]  C. Franceschi,et al.  Association between the MHC class I gene HFE polymorphisms and longevity: a study in Sicilian population , 2002, Genes and Immunity.

[31]  J. Janowsky,et al.  Hormone replacement therapy and cognition: systematic review and meta-analysis. , 2001, JAMA.

[32]  J. Jolles,et al.  The nature of the effect of female gonadal hormone replacement therapy on cognitive function in post-menopausal women: a meta-analysis , 2000, Neuroscience.

[33]  L. Hy,et al.  Prevalence of AD among whites , 2000, Neurology.

[34]  S. Gandy,et al.  Ovariectomy and 17β-estradiol modulate the levels of Alzheimer’s amyloid β peptides in brain , 2000, Neurology.

[35]  E. Barrett-Connor,et al.  Effect of postmenopausal hormones on inflammation-sensitive proteins: the Postmenopausal Estrogen/Progestin Interventions (PEPI) Study. , 1999, Circulation.

[36]  M. Beal,et al.  Mitochondrial dysfunction in neurodegenerative diseases. , 1998, Biochimica et biophysica acta.

[37]  K. Yaffe,et al.  Estrogen therapy in postmenopausal women: effects on cognitive function and dementia. , 1998, JAMA.

[38]  P. Shughrue,et al.  Comparative distribution of estrogen receptor‐α and ‐β mRNA in the rat central nervous system , 1997, The Journal of comparative neurology.

[39]  R. Brinton,et al.  17 β-Estradiol Enhances the Outgrowth and Survival of Neocortical Neurons in Culture , 1997, Neurochemical Research.

[40]  V. Henderson Estrogen Replacement Therapy for the Prevention and Treatment of Alzheimer’s Disease , 1997 .

[41]  J. Trojanowski,et al.  Strategies for Improving the Postmortem Neuropathological Diagnosis of Alzheimer’s Disease , 1997, Neurobiology of Aging.

[42]  M. Mattson,et al.  Estrogens Attenuate and Corticosterone Exacerbates Excitotoxicity, Oxidative Injury, and Amyloid β‐Peptide Toxicity in Hippocampal Neurons , 1996, Journal of neurochemistry.

[43]  J. Simpkins,et al.  Estradiol enhances brain glucose uptake in ovariectomized rats , 1995, Brain Research Bulletin.

[44]  M. Folstein,et al.  Clinical diagnosis of Alzheimer's disease , 1984, Neurology.

[45]  P. Bédard,et al.  ŒSTROGENS AND EXTRAPYRAMIDAL SYSTEM , 1977, The Lancet.

[46]  X. Qiao,et al.  Sex steroids and vascular responses in hypertension and aging. , 2008, Gender medicine.

[47]  R. Brinton Impact of Estrogen Therapy on Alzheimer’s Disease , 2004, CNS drugs.

[48]  T. Di Paolo,et al.  Estrogenic modulation of brain activity: implications for schizophrenia and Parkinson's disease. , 2002, Journal of psychiatry & neuroscience : JPN.

[49]  C. Caruso,et al.  Analysis of hemochromatosis gene mutations in the Sicilian population: implications for survival and longevity. , 2002, Archives of gerontology and geriatrics. Supplement.

[50]  R. Traystman,et al.  Neuroprotective effects of female gonadal steroids in reproductively senescent female rats. , 2000, Stroke.

[51]  H. Matsuda,et al.  Estrogen Increases Cerebral and Cerebellar Blood Flows in Postmenopausal Women , 1995 .

[52]  C. Toran-Allerand Printed in U.S.A. Copyright © 2004 by The Endocrine Society doi: 10.1210/en.2003-1462 Minireview: A Plethora of Estrogen Receptors in the Brain: Where Will It End? , 2022 .